Clinical Trials Browser

Phase 1/2 × azeliragon × 30 days × Clear all

NCT05635734 2026-05-29

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Phase 1/2 Completed

Glioblastoma